• NPS PHARMACEUTICALS INC Financial Overview

  • Income Statement: NPSP

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 86.25 M 48.50 M 37.75 M 43.76%
    Gross Profit 73.86 M -24.29 M 98.15 M 132.88%
    Net Income Before Extra Items/Preferred Div -4.28 M -112.67 M 108.39 M -2,531.20%
    Operating Income 8.14 M -76.46 M 84.60 M 1,039.23%
  • Cash Flow: NPSP

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing -35.48 M -8.08 M -27.40 M 77.22%
    Net Cash Flow - Investing -62.63 M -49.25 M -13.38 M 21.37%
    Net Cash Flow/Operating Activities 27.60 M -103.91 M 131.51 M 476.47%
  • Balance Sheet: NPSP

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 231.85 M 224.74 M 7.11 M 3.07%
    Total Liabilities 423.51 M 417.98 M 5.52 M 1.30%
    Shareholders Equity -191.66 M -193.24 M 1.59 M -0.83%
  • Key Ratios / Statistics: NPSP

    • Valuation

      Price/Earnings (TTM) -42.56
      Price/Sales (TTM) 2.08
      Price/Book (MRQ) -1.07
      Price/Cash Flow (TTM) 7.82
    • Profitability

      Gross Margin 85.64
      Operating Margin 9.44
      Profit Margin -4.96
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.16
      Current Ratio (MRQ) 2.92
      Long Term Debt-to-Equity (MRQ) -166.00
    • Management Effectiveness

      Return on Equity (TTM) -326.53
      Return on Assets (TTM) 34.97
      Return on Investments (TTM) 12.53